Planta Med 2012; 78(14): 1562-1567
DOI: 10.1055/s-0032-1315146
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

In Vitro Acanthamoebicidal Activity of Fusaric Acid and Dehydrofusaric Acid from an Endophytic Fungus Fusarium sp. Tlau3

Narumon Boonman
1   Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand
,
Surasak Prachya
2   Chulabhorn Research Institute, Laksi, Bangkok, Thailand
,
Atsadang Boonmee
1   Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand
,
Prasat Kittakoop
2   Chulabhorn Research Institute, Laksi, Bangkok, Thailand
3   Chulabhorn Graduate Institute, Chemical Biology Program, Laksi, Bangkok, Thailand
,
Suthep Wiyakrutta
1   Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand
,
Nongluksna Sriubolmas
4   School of Pharmacy, Eastern Asia University, Pathumthani, Thailand
,
Saradee Warit
5   TB Research Laboratory, National Center for Genetic Engineering and Biotechnology, NSTDA, Pathumthani, Thailand
,
Araya Dharmkrong-at Chusattayanond
1   Department of Microbiology, Faculty of Science, Mahidol University, Bangkok, Thailand
› Author Affiliations
Further Information

Publication History

received 08 February 2012
revised 02 July 2012

accepted 05 July 2012

Publication Date:
03 August 2012 (online)

Abstract

Acanthamoeba is a genus of free-living protozoa that can cause sight- and life-threatening diseases in man. Its control is still problematic due to the lack of effective and nontoxic acanthamoebicidal agents. Herein, we report the first finding of an in vitro killing effect of fusaric acid and dehydrofusaric acid, isolated from metabolites of the Fusarium fujikuroi species complex Tlau3, on Acanthamoeba trophozoites isolated from two clinical (AS, AR) and two soil (S3, S5) samples. AS, AR, and S3 were classified as members of the T4 genotype, whereas S5 belongs to T5. The fungal extract was found to exhibit acanthamoebicidal activity, and activity-guided fractionation led to the isolation and identification of active principles, fusaric acid and dehydrofusaric acid. Their effects were in concentration- and time-dependent manners. Fusaric acid and dehydrofusaric acid showed IC50 values against AS trophozoites of 0.31 and 0.34 µM, respectively. Commercial fusaric acid displayed the same acanthamoebicidal activity as that of the isolated fusaric acid, and therefore, commercial fusaric acid was used throughout this study. IC50 values of commercial fusaric acid against AR, S3, and S5 trophozoites were 0.33, 0.33, and 0.66 µM, respectively. Fusaric acid calcium salt has a history of usage as a hypotensive agent in humans with no observed toxicity. The present study suggests that fusaric acid may serve as a starting point for the development towards therapeutic and environmental acanthamoebicides with low toxicity to humans.

Supporting Information

 
  • References

  • 1 Marciano-Cabral F, Cabral G. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16: 273-307
  • 2 Khan NA. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiol Rev 2006; 30: 564-595
  • 3 Pussard M, Pons R. Morphologies de la paroi kystique et taxonomie du genre Acanthamoeba (Protozoa, Amoebida). Protistologica 1977; 13: 557-598
  • 4 Schroeder JM, Booton GC, Hay J, Niszl IA, Seal DV, Markus MB, Fuerst PA, Byers TJ. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of Acanthamoebae from humans with keratitis and from sewage sludge. J Clin Microbiol 2001; 39: 1903-1911
  • 5 Stratford MP, Griffith AJ. Variations in the properties and morphology of cysts of Acanthamoeba castellanii . J Gen Microbiol 1978; 108: 33-37
  • 6 Stothard DR, Schroeder-Diedrich JM, Awwad MH, Gast RJ, Ledee DR, Rodriguez-Zaragoza S, Dean CL, Fuerst PA, Byers TJ. The evolutionary history of the genus Acanthamoeba and the identification of eight new 18S rRNA gene sequence types. J Eukaryot Microbiol 1998; 45: 45-54
  • 7 Horn M, Fritsche TR, Gautom RK, Schleifer KH, Wagner M. Novel bacterial endosymbionts of Acanthamoeba spp. related to the Paramecium caudatum symbiont Caedibacter caryophilus . Environ Microbiol 1999; 1: 357-367
  • 8 Gast RJ. Development of an Acanthamoeba-specific reverse dot-blot and the discovery of a new ribotype. J Eukaryot Microbiol 2001; 48: 609-615
  • 9 Hewett MK, Robinson BS, Monis PT, Saint CP. Identification of a new Acanthamoeba 18S rRNA gene sequence type, corresponding to the species Acanthamoeba jacobsi Sawyer, Nerad and Visvesvara, 1992 (Lobosea: Acanthamoebidae). Acta Protozool 2003; 42: 325-329
  • 10 Corsaro D, Venditti D. Phylogenetic evidence for a new genotype of Acanthamoeba (Amoebozoa, Acanthamoebida). Parasitol Res 2010; 107: 233-238
  • 11 Nuprasert W, Putaporntip C, Pariyakanok L, Jongwutiwes S. Identification of a novel T17 genotype of Acanthamoeba from environmental isolates and T10 genotype causing keratitis in Thailand. J Clin Microbiol 2010; 48: 4636-4640
  • 12 Booton GC, Visvesvara GS, Byers TJ, Kelly DJ, Fuerst PA. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol 2005; 43: 1689-1693
  • 13 Ledee DR, Iovieno A, Miller D, Mandal N, Diaz M, Fell J, Fini ME, Alfonso EC. Molecular identification of T4 and T5 genotypes in isolates from Acanthamoeba keratitis patients. J Clin Microbiol 2009; 47: 1458-1462
  • 14 Martinez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol 1997; 7: 583-598
  • 15 Dharmkrong-at Chusattayanond A, Paveenkittiporn W, Dejsirilert S, Suchaoin S. Demonstration of serogroup-6 Legionella pneumophila in soil Acanthamoebae. Proceedings of the IXth International Meeting on the Biology and Pathogenicity of Free-Living Amoeba. Paris: John Libbey Eurotext; 2001: 151-154
  • 16 Iovieno A, Ledee DR, Miller D, Alfonso EC. Detection of bacterial endosymbionts in clinical acanthamoeba isolates. Ophthalmology 2010; 117: 445-452 (452.e1-3)
  • 17 La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, Birtles R, Claverie J, Raoult D. A giant virus in Amoebae. Science 2003; 299: 2033
  • 18 Lorenzo-Morales J, Coronado-Alvarez N, Martinez-Carretero E, Maciver SK, Valladares B. Detection of four adenovirus serotypes within water-isolated strains of Acanthamoeba in the Canary Islands, Spain. Am J Trop Med Hyg 2007; 77: 753-756
  • 19 Strobel G, Daisy B, Castillo U, Harper J. Natural products from endophytic microorganisms. J Nat Prod 2004; 67: 257-268
  • 20 Guo B, Wang Y, Sun X, Tang K. Bioactive natural products from endophytes: a review. Appl Biochem Microbiol 2008; 44: 153-158
  • 21 Boonman N, Wiyakrutta S, Sriubolmas N, Dharmkrong-at Chusattayanond A. Acanthamoebicidal activity of Fusarium sp. Tlau3, an endophytic fungus from Thunbergia laurifolia Lindl. Parasitol Res 2008; 103: 1083-1090
  • 22 Stipanovic RD, Wheeler MH, Puckhaber LS, Liu J, Bell AA, Williams HJ. Nuclear magnetic resonance (NMR) studies on the biosynthesis of fusaric acid from Fusarium oxysporum f. sp. vasinfectum . J Agric Food Chem 2011; 59: 5351-5356
  • 23 Capasso R, Evidente A, Cutignano A, Vurro M, Zonno MC, Bottalico A. Fusaric and 9,10-dehydrofusaric acids and their methyl esters from Fusarium nygamai . Phytochemistry 1996; 41: 1035-1039
  • 24 Shoff M, Rogerson A, Schatz S, Seal D. Variable responses of Acanthamoeba strains to three multipurpose lens cleaning solutions. Optom Vis Sci 2007; 84: 202-207
  • 25 Doberstein SK, Baines IC, Wiegand G, Korn ED, Pollard TD. Inhibition of contractile vacuole function in vivo by antibodies against myosin-I. Nature 1993; 365: 841-843
  • 26 Lee JE, Oum BS, Choi HY, Yu HS, Lee JS. Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea 2007; 26: 736-741
  • 27 Hidaka H, Nagatsu T, Takeya K, Takeuchi T, Suda H. Fusaric acid, a hypotensive agent produced by fungi. J Antibiot 1969; 22: 228-230
  • 28 Terasawa F, Ying LH, Kameyama M. The hypotensive effect of fusaric acid: the results of long-term administration of fusaric acid in elderly hypertensive patients. Jpn Circ J 1976; 40: 1017-1023